187 related articles for article (PubMed ID: 9557732)
21. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.
Xu X; Kang SH; Heidenreich O; Okerholm M; O'Shea JJ; Nerenberg MI
J Clin Invest; 1995 Sep; 96(3):1548-55. PubMed ID: 7657825
[TBL] [Abstract][Full Text] [Related]
22. Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1.
Bovolenta C; Pilotti E; Mauri M; Panzeri B; Sassi M; Dall'Aglio P; Bertazzoni U; Poli G; Casoli C
J Immunol; 2002 Oct; 169(8):4443-9. PubMed ID: 12370379
[TBL] [Abstract][Full Text] [Related]
23. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression.
Collins ND; D'Souza C; Albrecht B; Robek MD; Ratner L; Ding W; Green PL; Lairmore MD
J Virol; 1999 Nov; 73(11):9642-9. PubMed ID: 10516077
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.
Yu CL; Jove R; Burakoff SJ
J Immunol; 1997 Dec; 159(11):5206-10. PubMed ID: 9548458
[TBL] [Abstract][Full Text] [Related]
25. The functional role of the JAK-STAT pathway in post-infarction remodeling.
El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
[TBL] [Abstract][Full Text] [Related]
26. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
[TBL] [Abstract][Full Text] [Related]
27. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
Liu J; Kern JA
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
[TBL] [Abstract][Full Text] [Related]
28. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
Samaan A; Mahana W
Immunol Lett; 2007 Apr; 109(2):113-9. PubMed ID: 17368812
[TBL] [Abstract][Full Text] [Related]
29. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
30. [Growing divergence inside primate T cell lymphotropic viruses].
Van Brussel M; Vandamme AM
Verh K Acad Geneeskd Belg; 1999; 61(1):39-63. PubMed ID: 10379197
[TBL] [Abstract][Full Text] [Related]
31. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.
Migone TS; Humbert M; Rascle A; Sanden D; D'Andrea A; Johnston JA
Blood; 2001 Sep; 98(6):1935-41. PubMed ID: 11535532
[TBL] [Abstract][Full Text] [Related]
32. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
33. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
34. Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II.
Giri A; Markham P; Digilio L; Hurteau G; Gallo RC; Franchini G
J Virol; 1994 Dec; 68(12):8392-5. PubMed ID: 7966632
[TBL] [Abstract][Full Text] [Related]
35. The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs.
Van Brussel M; Salemi M; Liu HF; Goubau P; Desmyter J; Vandamme AM
Rev Med Virol; 1999 Jul; 9(3):155-70. PubMed ID: 10479777
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
37. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
38. Jak-STAT signaling induced by the v-abl oncogene.
Danial NN; Pernis A; Rothman PB
Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
[TBL] [Abstract][Full Text] [Related]
39. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
